Weight loss drug reduced risk of COVID deaths in new study ...Middle East

The Hill - News
Weight loss drug reduced risk of COVID deaths in new study
A popular weight loss drug reduced the risk of COVID-19 deaths, according to a new study. The research, published Friday in the Journal of the American College of Cardiology, found during a clinical trial of Wegovy that people taking the obesity drug during the COVID pandemic were less likely to die from the virus. Semaglutide, the active medicine found in the drug, has become a popular option for people looking to lose weight. Wegovy has been widely used along with Ozempic — both medicines are also used for the treatment of Type 2 diabetes. People taking the drug still contracted the virus during the clinical trial, but their chances of dying dropped by 33 percent, the study fou

Hence then, the article about weight loss drug reduced risk of covid deaths in new study was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Weight loss drug reduced risk of COVID deaths in new study )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News